Skip to main content

crIpeC nAnomedicines’ micRodistribution in tUmour tiSsue

Project description

Delivering personalised nanomedicine at the tumour microenvironment

There are many diseases with unmet medical needs including cancer. Nanotechnology has emerged as a promising solution for encapsulating drugs and increasing their stability and biodistribution. The EU-funded ICARUS project is interested to improve the efficacy and therapeutic outcome of custom-made anti-cancer nanomedicines. These nanomedicines are biodegradable and demonstrate a great pharmacokinetic profile. During ICARUS, researchers plan to develop innovative state-of-the-art analytical methodologies that will help elucidate the distribution and behaviour of these nanomedicines at the tumour microenvironment. Results will pave the way for better-tolerated drugs in comparison to conventional treatment modalities.

Call for proposal

H2020-INNOSUP-2018-2020

See other projects for this call

Sub call

H2020-INNOSUP-2020-02

Coordinator

CRISTAL DELIVERY BV
Net EU contribution
€ 128 875,00
Address
Oxfordlaan 55
6229 EV Maastricht
Netherlands

See on map

Region
Limburg (NL) Zuid-Limburg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
No data